"TG Laser es una clínica dedicada a brindar atención médica especializada en oftalmología, personalizada y con la más alta calidad, sustentada en la actualización científica permanente."

During the past decade, TG Laser Oftalmica conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 3 clinical trials were completed, i.e. on average, 75% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 3 clinical trials were completed. i.e. 300% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "TG Laser Oftalmica" are "Diabetic Macular Edema" (2 trials) and "Geographic Atrophy" (2 trials). Many other conditions were trialed in "TG Laser Oftalmica" in a lesser frequency.

Most popular intervention types in "TG Laser Oftalmica" are "Drug" (4 trials), "Other" (2 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Faricimab" (2 trials), "Lampalizumab" (2 trials), "Sham Procedure" (2 trials), "Aflibercept" (1 trials) and "Sham Comparator" (1 trials). Other intervention names were less common.

The vast majority of trials in "TG Laser Oftalmica" are 4 trials for "All" genders.

Currently, there are NaN active trials in "TG Laser Oftalmica". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in TG Laser Oftalmica, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in TG Laser Oftalmica, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".